{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:55:34Z","timestamp":1762458934551,"version":"3.44.0"},"reference-count":0,"publisher":"SMW Supporting Association","issue":"4546","license":[{"start":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T00:00:00Z","timestamp":1320624000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Swiss Med Wkly"],"abstract":"<jats:p>To prevent  osteoporotic fracture occurrence, a variety of treatment regimens with  different mechanisms of action is available. The\u00a0antiresorptive bisphosphonate  drugs are currently the most commonly prescribed agents in the management of  patients with osteoporosis. The\u00a0recombinant amino-terminal fragment of human  parathyroid hormone (Teriparatide) is a bone anabolic agent which reduces  fracture risk by increasing bone mass and improving bone microarchitecture.  Teriparatide treatment reduces vertebral and non-vertebral fracture risk markedly  in women and men with idiopathic osteoporosis, or with glucocorticoid-induced osteoporosis. Teriparatide should thus be  considered as first line treatment for postmenopausal women and for men with  severe osteoporosis.<\/jats:p>","DOI":"10.4414\/smw.2011.13297","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T17:31:00Z","timestamp":1320687060000},"page":"w13297","source":"Crossref","is-referenced-by-count":3,"title":["Indications to teriparatide treatment in  patients with osteoporosis"],"prefix":"10.57187","volume":"141","author":[{"given":"R","family":"Rizzoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kraenzlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Lippuner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36756","published-online":{"date-parts":[[2011,11,7]]},"container-title":["Swiss Medical Weekly"],"original-title":[],"link":[{"URL":"https:\/\/smw.ch\/index.php\/smw\/article\/download\/1378\/1640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/smw.ch\/index.php\/smw\/article\/download\/1378\/1641","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/smw.ch\/index.php\/smw\/article\/download\/1378\/1640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T03:19:16Z","timestamp":1755227956000},"score":1,"resource":{"primary":{"URL":"https:\/\/smw.ch\/index.php\/smw\/article\/view\/1378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,7]]},"references-count":0,"journal-issue":{"issue":"4546","published-online":{"date-parts":[[2011,11,7]]}},"URL":"https:\/\/doi.org\/10.4414\/smw.2011.13297","relation":{},"ISSN":["1424-3997"],"issn-type":[{"type":"electronic","value":"1424-3997"}],"subject":[],"published":{"date-parts":[[2011,11,7]]}}}